Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 28, 2024

Outcomes of Pro Re Nata vs Treat-and-Extend Anti-VEGF Injections for Myopic Macular Neovascularization in Multiethnic Patients in the US

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
Outcomes of Pro Re Nata versus Treat-and-Extend Anti-VEGF Injections for Myopic Macular Neovascularization in Multiethnic Patients in the United States
Retina (Philadelphia, Pa.) 2024 Dec 01;44(12)2057-2065, S Swaminathan, R Mahmoudzadeh, T Wakabayashi, M Bowers, B Momenaei, RM Abishek, M Salabati, J Hsu, JP Dunn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading